Aarti Drugs posts Q4 FY24 consolidated PAT at Rs. 47.37 Cr

Aarti Drugs posts Q4 FY24 consolidated PAT at Rs. 47.37 Cr

By: IPP Bureau

Last updated : May 09, 2024 12:06 pm



The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024


Aarti Drugs Limited has reported Consolidated financial results for the period ended March 31, 2024.

Aarti Drugs Limited has posted net profit of Rs. 47.37 crores for the period ended March 31, 2024 as against net profit of Rs. 36.67 crores for the period ended December 31, 2023. The company posted net profit of Rs.56.09 crores for the period ended March 31, 2023.

Aarti Drugs Limited has reported total income of Rs. 621.07 crores during the period ended March 31, 2024 as compared to Rs. 607.61 crores during the period ended December 31, 2023. The company reported total income of Rs.743.28 crores during the period ended March 31, 2023.

For the Financial Year ended March 31, 2024, Aarti Drugs Limited has reported total income of Rs. 2,532.61 crores as compared to Rs. 2,718.25 crores during the Financial Year ended March 31, 2023.

The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024 as against net profit of Rs.166.31 crores for the Financial Year ended March 31, 2023.

Aarti Drugs Limited

First Published : May 09, 2024 12:00 am